JanOne Inc. Share Price Deutsche Boerse AG
Equities
5AR1
US47089W1045
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.94 EUR | +2.08% | +4.26% | +503.08% |
Sales 2022 | 3.96Cr 3.65Cr 330.4Cr | Sales 2023 | - | Capitalization | 27.51L 25.37L 23Cr |
---|---|---|---|---|---|
Net income 2022 | 1.1Cr 1.01Cr 92Cr | Net income 2023 | -70L -64.55L -58Cr | EV / Sales 2022 | 0.41 x |
Net Debt 2022 | 1.2Cr 1.11Cr 100.28Cr | Net Debt 2023 | 4L 4L 3.47Cr | EV / Sales 2023 | - |
P/E ratio 2022 |
0.39
x | P/E ratio 2023 |
-0.28
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.07% |
1 day | +2.08% | ||
1 week | +4.26% | ||
1 month | -10.91% | ||
3 months | +198.48% | ||
6 months | +693.52% | ||
Current year | +503.08% |
Managers | Title | Age | Since |
---|---|---|---|
Antonios Isaac
CEO | Chief Executive Officer | 71 | 01/15/01 |
Virland Johnson
DFI | Director of Finance/CFO | 64 | 21/17/21 |
Amol Soin
CTO | Chief Tech/Sci/R&D Officer | - | 29/20/29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Antonios Isaac
CEO | Chief Executive Officer | 71 | 01/15/01 |
Richard Butler
BRD | Director/Board Member | 74 | 01/15/01 |
Nael Hajjar
BRD | Director/Board Member | 40 | 01/18/01 |
Date | Price | Change |
---|---|---|
31/24/31 | 2.94 | +2.08% |
30/24/30 | 2.88 | +1.41% |
29/24/29 | 2.84 | +0.71% |
28/24/28 | 2.82 | -12.42% |
27/24/27 | 3.22 | +14.18% |
Delayed Quote Deutsche Boerse AG, May 31, 2024 at 07:29 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+43.36% | 5.46TCr | |
-5.31% | 3.99TCr | |
+14.75% | 2.69TCr | |
-12.56% | 2.62TCr | |
-22.45% | 1.88TCr | |
+25.12% | 1.22TCr | |
+0.04% | 1.22TCr | |
+26.04% | 1.19TCr | |
-11.83% | 1.07TCr |
- Stock Market
- Equities
- JAN Stock
- 5AR1 Stock